Spondyloarthropathies
News
Psoriatic arthritis patients often changed or stopped treatment
Key clinical point: Patients with psoriatic arthritis who started taking a nonbiologic disease-modifying antirheumatic drug often changed...
Conference Coverage
Jury still out on effect of systemic psoriasis meds on MI risk
News
Anti-adalimumab antibodies mean poorer outcomes in psoriatic arthritis
Key clinical point: The presence of anti-adalimumab antibodies results in lower adalimumab concentrations and poorer clinical outcome.Major...
Conference Coverage
Link between autoimmune therapy, preterm birth is largely due to confounding
Key clinical point: Confounders at least partially explain the heightened risk of preterm birth associated with autoimmune therapy.Major finding:...
Conference Coverage
Multicenter cooperative psoriatic arthritis study group formed
Guidelines
Conventional DMARDs may be excluded from psoriatic arthritis enthesitis guidelines
Conference Coverage
Too few U.S. rheumatologists see patients with axial spondyloarthritis
Conference Coverage
Depression may run with opiate use in patients with ankylosing spondylitis
Key clinical point: Patients with ankylosing spondylitis who use opiates are far more likely to self-report depression than are those who do not...
Conference Coverage
Cardiovascular risk remains difficult to characterize in ankylosing spondylitis
Guidelines
New guidelines proposed for nail involvement in psoriatic arthritis
Conference Coverage
Early biologics may halt ankylosing spondylitis progression
Key clinical point: Early initiation of TNF inhibitors in AS appears to greatly reduce progression as characterized by new bone formation.